Morphoceuticals: Jobs, Salaries & Tech Stack (2026)

Funding and backers

Total raised

$13.3M

2 rounds on record

Latest round

$3.5M

Venture round · Sep 2024 · 2 yr ago

Team

11-50

employees, estimated range

The money's age

Due for its next round

24 months since the last round · not hiring

Momentum

0/100

no fresh signals

Last sign of life

this month

a posting or a news item

The story so fareach stage dated by its source: the company's releases, the press, registers, filings

Sep 23, 2024 Raised a round Venture round $3.5M · SEC Form D Apr 17, 2024 New executive Morphoceuticals Names Jim Jenson, PhD as CEO to Advance AI-Guided Regenerative Medicine Technology · streetinsider.com Jan 13, 2023 Raised a round Venture round $9.8M · SEC Form D 2020 Founded

Funding rounds

Round	Date	Amount	Investors	Source
Venture round	Sep 2024	$3.5M	—	SEC Form D
Venture round	Jan 2023	$9.8M	—	SEC Form D

Registers and programsofficial lists and records that name the company

Legal entity

Morphoceuticals, Inc.

SEC Form D

Founders and leadersfrom filings, registers and the company's site

David GillExecutive OfficerSEC Form D

Michael HuffordDirectorSEC Form D

James JensonExecutive Officer, DirectorSEC Form D

Similar startupsby what they do, their industry and backers

Eterna RegenerativesVenture round $4M · this month • 11-50 employees

Eterna Regeneratives develops regenerative biomaterials for mineralisation and tissue regeneration, with initial applications in oral…

GlycologixVenture round $800k · 9 mo ago • Founded 2021 • 11-50 employees

GlycoLogix - A ground-breaking therapy for Interstitial Cystitis / Bladder Pain Syndrome, developing biopolymers for soft tissue repair.

TrajectoryVenture round $15M · 3 mo ago

-Our Mission 誰もが空の恩恵を享受できる世界を実現するトラジェクトリーは、管制の自動化を通じて、誰もが安全かつ簡単に無人航空機の恩恵を享受できる社会を実現し、人々のQOL（Quality of Life）の向上に貢献するというミッションを掲げています。.

Granza Bio

Reprogramming Immunity for Target-Specific Medicines.

Hilltop Bio'Founded 2018

Hilltop Bio's veterinary regenerative therapies are engineered to take healing to the next level for joint health, soft tissue repair, and…

Frontier Bio51-200 employees

Frontier Bio develops living vascular grafts and in-vitro tissue platforms, building the foundation for organ-scale engineered tissues.

Overview

Reprogramming the Software of Life: Understanding the bioelectric network that controls tissue repair and organ regeneration.

News

News YahooFinance 1 year ago

Morphoceuticals Announces Roger Pomerantz, MD, as Chairman of its Board of Directors

Roger Pomerantz, MD Roger Pomerantz, MD MEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Morphoceuticals Inc., a TechBio company pioneering AI-guided electroceuticals for tissue repair and organ regeneration, today announced the appointment of industry v